Advertisement
Research Article Free access | 10.1172/JCI107799
Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Find articles by Revak, S. in: JCI | PubMed | Google Scholar
Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Find articles by Cochrane, C. in: JCI | PubMed | Google Scholar
Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Find articles by Johnston, A. in: JCI | PubMed | Google Scholar
Department of Experimental Pathology, Scripps Clinic and Research Foundation, La Jolla, California 92037
Find articles by Hugli, T. in: JCI | PubMed | Google Scholar
Published September 1, 1974 - More info
The structure of Hageman factor, isolated from human plasma, was analyzed before and after enzymatic activation. The purified molecule is a single polypeptide chain of 80,000 molecular weight (mol wt) sedimenting at 4.5S. An amino acid analysis has been performed. The concentration of Hageman factor in normal human plasma was found to be 29 μg/ml with variation between individuals ranging from 15 to 47 μg/ml. Treatment of the molecule with kallikrein, plasmin, or trypsin resulted in cleavage at two primary sites, yielding fragments of 52,000, 40,000, and 28,000 mol wt. No further changes occurred in the fragments with subsequent reduction. Prekallikrein-activating ability was associated exclusively with the 28,000 moiety.